Press and Media

HarborPath Launches National Advisory Board to Strengthen Opioid Response

CHARLOTTE (July 1, 2025) – HarborPath, a national nonprofit dedicated to providing life-saving specialty medications to underinsured and vulnerable populations, has announced the formation of a new advisory board composed of eight distinguished leaders from across the United States. The board includes experts in public policy, medicine, pharmaceutical distribution and advocacy - many of whom have been personally impacted by the overdose crisis.

2025-07-01

Millions in opioid settlement funds sit unspent when lives could be saved

When 23-year-old William Magee drew his last breath, he was a recent graduate of the University of Mississippi, where he was enrolled in the Honors College, had lettered in track and was plotting his future as a lawyer. His father, David Magee, found his body on his apartment floor, dead from an opioid overdose of something that probably was or included fentanyl, a relatively little-understood drug at the time.

2024-03-25

Millions in opioid settlement funds sit unspent when lives could be saved

When 23-year-old William Magee drew his last breath, he was a recent graduate of the University of Mississippi, where he was enrolled in the Honors College, had lettered in track and was plotting his future as a lawyer. His father, David Magee, found his body on his apartment floor, dead from an opioid overdose of something that probably was or included fentanyl, a relatively little-understood drug at the time.

2024-03-25

Nonprofit HarborPath partners with Ole Miss athletes to combat fentanyl crisis

OXFORD, Miss. – In response to the alarming rise of fentanyl poisonings and drug overdoses nationwide, the nonprofit HarborPath unveiled Tuesday a pioneering awareness campaign aimed at protecting college students and saving lives. Leveraging Name, Image, and Likeness (NIL), HarborPath is collaborating with student-athletes from the University of Mississippi to connect students with life-saving resources.

2024-02-27